Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Active, not recruiting	Phase 2	2024-07-03		NCT06138769

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Asan Medical Center	114
Bucheon St. Mary's Hospital	7
Bundang CHA Hospital	10
Chonnam National University Hospital	54
Chosun University Hospital	5
Chungbuk National University Hospital	9
Chungnam National University Hospital	34
Dong-A University Hospital	9
Eisai Inc.	40
Ewha Womans University	6
Gachon University Gil Medical Center	10
Gangneung Asan Hospital	3
Gyeongsang National University Hospital	14
Hanyang University Seoul Hospital	10
Saint Vincent's Hospital, Korea	15
Seoul National University	14
Seoul National University Bundang Hospital	114
Severance Hospital	45
The Catholic University of Korea	20
Ulsan University Hospital	20
Yonsei University	213

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asan Medical Center	Seoul	South Korea	338

Clinical trials